ClinicalTrials.gov
ClinicalTrials.gov Menu

Analgesic Efficacy of Intravenous Lidocaine and/or Ketamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01439399
Recruitment Status : Completed
First Posted : September 23, 2011
Last Update Posted : September 23, 2011
Sponsor:
Information provided by (Responsible Party):
Joray Florence, University of Lausanne Hospitals

Brief Summary:
The aim of the present study is to evaluate the analgesic benefit of intravenous lidocaine and ketamine in the perioperative period of abdominal surgery.

Condition or disease Intervention/treatment Phase
Postoperative Pain Drug: Lidocaine, Drug: Ketamine Drug: association ketamine-lidocaine Drug: Placebo Not Applicable

Detailed Description:
Optimal postoperative pain management facilitates rehabilitation immediately after abdominal surgery. Multiple studies have demonstrated that successful postoperative analgesia also reduces perioperative complications and improves patient comfort, thereby providing many benefits for the patient. In acute postoperative pain management intravenous lidocaine and/or ketamine have been advocated because of their morphine-sparing effect.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 52 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Analgesic Efficacy of Intravenous Perfusion of Lidocaine, Ketamine or a Combination After Laparotomy in a Placebo-controlled, Randomized, Double-blind Prospective Study
Study Start Date : December 2005
Actual Primary Completion Date : July 2007
Actual Study Completion Date : July 2007

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Lidocaine
Intravenous lidocaine administered preoperatively (anesthesia induction) and postoperatively during 48 hours
Drug: Lidocaine,
Lidocaine group received an IV bolus of 1.5 mg.kg-1 followed by a continuous infusion of 2 mg.kg-1.h-1 intraoperative and 1.33 mg.kg-1.h-1 for 48 h postoperative.

Active Comparator: Ketamine
Intravenous ketamine administered preoperatively (anesthesia induction) and postoperatively during 48 hours
Drug: Ketamine
Ketamine group received a bolus of 0.5 mg.kg-1, then 0.25 mg.kg-1.h-1 followed by 0.1 mg.kg-1.h-1 for the first 24 h, then 0.05 mg.kg-1.h-1 for the next 24 h.

Active Comparator: Ketamine-Lidocaine
Intravenous association of ketamine and lidocaine administered preoperatively (at anesthesia induction) and postoperatively during 48 hours.
Drug: association ketamine-lidocaine
Ketamine-lidocaine group received a bolus of 1.5 mg.kg-1 of lidocaine and 0.5 mg.kg-1 of ketamine, a continuous infusion of 1.3 mg.kg-1.h-1 of lidocaine and 0.17 mg.kg-1.h-1 of ketamine was delivered followed by 0.9 mg.kg-1 of lidocaine with 0.08 mg.kg-1.h-1 of ketamine during 48 h, the dose of ketamine being reduced to 0.04 mg.kg-1.h-1 after the first 24 hours.

Placebo Comparator: Saline 0,9%
Control group
Drug: Placebo
The control group (C) received an equal volume of saline 0.9 % during 48 h.




Primary Outcome Measures :
  1. Cumulative morphine consumption [ Time Frame: 48 hours ]
    Cumulative morphine consumption over 48 hours postoperatively


Secondary Outcome Measures :
  1. Pain scores [ Time Frame: 48 hours ]
    Pain scores at rest and movement

  2. Mechanical hyperalgesia [ Time Frame: 48 hours ]
    Mechanical hyperalgesia using pressure algometry

  3. Occurrence of side effects [ Time Frame: 48 hours ]
    Occurrence of side effects: sedation, nausea, vomiting, itching, nightmares



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • abdominal surgery by laparotomy

Exclusion Criteria:

  • laparoscopy
  • history of chronic pain
  • opioid self-administration
  • psychiatric disorders
  • difficulties with communication
  • renal or hepatic dysfunction
  • ASA physical status > 3

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01439399


Locations
Switzerland
University Hospital Center and University
Lausanne, Vaud, Switzerland, CH-1011
Sponsors and Collaborators
University of Lausanne Hospitals
Investigators
Study Director: Christian Kern University of Lausanne Hospitals

Responsible Party: Joray Florence, Chief Resident, University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT01439399     History of Changes
Other Study ID Numbers: KL-48h
179/05 ( Other Identifier: Cantonal Ethics Committee of Research on human )
First Posted: September 23, 2011    Key Record Dates
Last Update Posted: September 23, 2011
Last Verified: September 2011

Keywords provided by Joray Florence, University of Lausanne Hospitals:
postoperative pain
postoperative care
intravenous lidocaine
intravenous ketamine
morphine consumption

Additional relevant MeSH terms:
Pain, Postoperative
Pain
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Lidocaine
Ketamine
Analgesics
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents